Keyphrases
Serum Antibody
100%
Antibody Response
100%
Vaccine Candidate
100%
Human Serum
100%
Tetravalent Dengue Vaccine
100%
Live Attenuated Tetravalent Dengue Vaccine
100%
Vaccine Response
75%
Epitope
50%
Envelope Protein
50%
DENV-1
50%
Type-specific
50%
Neutralizing Antibodies
50%
Neutralizing Epitope
50%
DENV-3
50%
Protective Immunity
25%
Recombinant
25%
Etiological Agents
25%
Clinical Trials
25%
Monoclonal Antibody
25%
Vector-borne
25%
Dengue
25%
Dengue Fever
25%
Viral Pathogens
25%
Safety Assessment
25%
Hemorrhagic Disease
25%
Epitope Specificity
25%
Serotype-specific
25%
Efficacy Evaluation
25%
DENV-2
25%
Vaccine Administration
25%
Qualitative Measures
25%
Qualitative Features
25%
Dengue Virus Serotype 1
25%
Common Vector
25%
Immunology and Microbiology
Antibody Response
100%
Antibody Blood Level
100%
Serum (Blood)
100%
Dengue Vaccine
100%
Epitope
83%
Dengue Virus
66%
Serotype
33%
Neutralizing Antibody
33%
Dengue Fever
33%
Dengue Virus 1
33%
Dengue Virus 3
33%
Infectious Agent
16%
Human Monoclonal Antibody
16%
Dengue Virus 2
16%